Advertisement

Supply Chain



Fagron agreed to pay $22.05 million to resolve allegations that its subsidiary, Freedom Pharmaceuticals, intentionally inflated average wholesale prices for its ingredients to increase reimbursements from federal healthcare programs.

The FDA is encouraging drugmakers to invest in production technologies that would bring manufacturing back to the U.S. as several recalls call into question the safety of the global drug supply chain, according to Bloomberg.

Medline is hosting a one-day national hiring event Nov. 7 seeking to hire 2,000 employees.

Advertisement

Most Read

Advertisement
Advertisement